Pfizer Animal Health has introduced a new vaccine, Bovi-Shield GOLD HB, that combines five-way viral protection with the prevention of Leptospira borgpetersenii serovar Hardjo type Hardjo-bovis, commonly known as Lepto hardjo-bovis.
Lepto hardjo-bovis is the most prevalent strain of leptospira in
“Lepto hardjo-bovis is an insidious reproductive problem,” said Glenn Rogers,
Bovi-Shield GOLD HB provides superior protection against five major viral pathogens: IBR, PI3, BRSV and BVD Types 1 and 2. Combine that with the prevention of infection label claim for Lepto hardjo-bovis, and Bovi-Shield GOLD HB offers producers convenience and flexibility with one vaccine that can be administered intramuscularly or subcutaneously.
Bovi-Shield GOLD HB offers unmatched duration of immunity versus competitive reproductive vaccines, with at least 365 days of immunity for IBR abortions, BVD Types 1 and 2 persistent infection, Lepto hardjo-bovis infection, and Lepto hardjo-bovis urinary shedding and kidney colonization.
For more information on Bovi-Shield GOLD HB, click here, or contact your local veterinarian, animal health supplier or Pfizer Animal Health representative.
Pfizer also offers a fact sheet on Lepto hardjo-bovis.